A Study to Improve the Collaboration Between Primary and Secondary Health Care on the Trea
This is a study to improve the collaboration between primary and secondary health care on the treatment of osteoporosis after a hip fracture. In Akershus University Hospital, patients 75 years or older with a hip fracture, are offered treatment with an infusion of zoledronic acid 5mg, combined with vitamin D and calciu
| Condition(s) | Hip Fractures, Osteoporosis, Zoledronic Acid, Ambulant Nurse, Case Manager |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | This is a study to improve the collaboration between primary and secondary health care on the treatment of osteoporosis after a hip fracture. In Akershus University Hospital, patients 75 years or older with a hip fracture, are offered treatment with an infusion of zoledronic acid 5mg, combined with vitamin D and calcium supplements, to prevent new fractures. General practitioners (GPs) are requested to take care of the follow-up on this treatment with annual infusions of zoledronic acid for 3 years. In the opinion of the investigators, it is expedient, safe, and sensible for parts of the subsequent treatment to be provided by GPs. If hospitals take responsibility for initiating the treatment, the investigators believe that most of the subsequent monitoring and continuance of treatment can |
| Who can participate | Inclusion Criteria: * Patients 75 years or older with a hip fracture Exclusion Criteria: * Refuse treatment * Another treatment of osteoporosis is indicated * Guest patient, do not live in the admission area * Dementia |
| Ages | 75 Years |
| Sex | All |
| Lead sponsor | University Hospital, Akershus |
| Locations | Lørenskog, Akershus, Norway |
| Start date | 2024-01-01 |
| NCT ID | NCT05904353 |
| Official listing | https://clinicaltrials.gov/study/NCT05904353 |